Evidence map›Paper›PMID 35990682›Full record

ArticleFrontiers in immunology2022

Emily C Ross, Arne L Ten Hoeve, Jeroen P J Saeij, Antonio Barragan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Article
  3. Bioactive materials · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. The emerging role ofFrontiers in immunology · 2024
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Emily C RossDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Arne L Ten HoeveDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Jeroen P J SaeijDepartment of Pathology, Microbiology, and Immunology, University of California, Davis, Davis, CA, United States.
Antonio BarraganDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Stockholm University · SEUniversity of California, Davis · US

Funding

Identify Toxoplasma genes that determine in vivo fitness with CRISPR-Cas9 genetic screensR21AI151084 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SAEIJ, JEROEN · 2020 to 2021
$432k
NIAID NIH HHS R21 AI151084
6 · The paper itself

Abstract

The obligate intracellular parasite

Indexed as

ToxoplasmaDendritic CellsEndotheliumIntercellular Adhesion Molecule-1Transendothelial and Transepithelial MigrationIntercellular Adhesion Molecule-1apicomplexablood-brain barriercell adhesion molecule (CAM)immune cellleukocytetrans-endothelial migration

Identifiers

PMID35990682
PMCPMC9381734
OpenAlexW4289517098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.